EZH2 and breast carcinoma: Due to the recently reported association between proliferative activity in breast epithelium and breast cancer risk [7, 8], we next cross-classified EZH2 with Ki67 and ER expression to evaluate the potential effect of Ki67 and ER expression on the association of epithelial EZH2 expression and subsequent breast cancer risk (Table 3).